Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg

Using Strategic Flexibility to Succeed in Emerging Pharmaceutical... Comments

');

');

Add a Comment

Email for more information
Company's other products
Email to a colleague
Printer friendly format

Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg

Watson Pharmaceuticals, Inc. has announced that its subsidiary, Watson Laboratories, Inc., has received final approval today from the FDA on its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets (XL) in the 150 mg strength. Bupropion Hydrochloride Extended-Release Tablets is the generic equivalent to GlaxoSmithKline's Wellbutrin XL(R) product, which is indicated for the treatment of major depressive disorder. Watson intends to launch the product immediately.

Talkback! Pharmaceutical Processing is pleased to provide you an opportunity to share your opinions on any of the news stories or articles on our site. We reserve the right to edit/remove comments.
Viewing 1 User Comments	Add a Comment

Generic Wellbutrin XL 5/28/2009 11:31:56 PM
Please advise where I can purchase Watson bupropion XL(generic Wellbutrin) near Rochester, NY. Thank you.

Add a Comment...

');